Anzeige
Mehr »
Login
Samstag, 27.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Nurexone Biologic: Jetzt diese wirklich einzigartige Chance ergreifen?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 856767 | ISIN: US0321591051 | Ticker-Symbol:
NASDAQ
26.04.24
22:00 Uhr
21,000 US-Dollar
+0,650
+3,19 %
Branche
Immobilien
Aktienmarkt
Sonstige
1-Jahres-Chart
AMREP CORPORATION Chart 1 Jahr
5-Tage-Chart
AMREP CORPORATION 5-Tage-Chart
GlobeNewswire (Europe)
47 Leser
Artikel bewerten:
(0)

AMREP Corporation: AMREP Reports Third Quarter Fiscal 2024 Results

HAVERTOWN, Pa., March 08, 2024 (GLOBE NEWSWIRE) -- AMREP Corporation (NYSE:AXR) today reported net income of $92,000, or $0.02 per diluted share, for its 2024 fiscal third quarter ended January 31, 2024 compared to net income of $16,574,000, or $3.12 per diluted share, for the same period of the prior year. For the first nine months of 2024, AMREP had net income of $2,546,000, or $0.48 per diluted share, compared to net income of $22,107,000, or $4.17 per diluted share, for the same period of 2023. Revenues were $12,689,000 and $31,833,000 for the third quarter and first nine months of 2024 and $9,117,000 and $35,975,000 for the third quarter and first nine months of 2023.

During the third quarter of 2023, AMREP recognized a non-cash pre-tax pension settlement expense of $2,336,000 as a result of its defined benefit pension plan paying certain lump sum payouts of pension benefits to former employees and a non-cash income tax benefit of $16,071,000 as a result of a worthless stock deduction related to its former fulfillment services business.

More information about the Company's financial performance may be found in AMREP Corporation's financial statements on Form 10-Q which have today been filed with the Securities and Exchange Commission and will be available on AMREP's website (www.amrepcorp.com/sec-filings/).

AMREP Corporation, through its subsidiaries, is a major holder of land, leading developer of real estate and award-winning homebuilder in New Mexico.

FINANCIAL HIGHLIGHTS
Three Months Ended January 31,
2024 2023
Revenues$12,689,000 $9,117,000
Net income$92,000 $16,574,000
Earnings per share - basic$0.02 $3.14
Earnings per share - diluted$0.02 $3.12
Weighted average number of common shares outstanding - basic 5,303,000 5,284,000
Weighted average number of common shares outstanding - diluted 5,346,000 5,310,000
Nine Months Ended January 31,
2024 2023
Revenues$31,833,000 $35,975,000
Net income$2,546,000 $22,107,000
Earnings per share - basic$0.48 $4.19
Earnings per share - diluted$0.48 $4.17
Weighted average number of common shares outstanding - basic 5,299,000 5,280,000
Weighted average number of common shares outstanding - diluted 5,341,000 5,304,000
CONTACT:Adrienne M. Uleau
Vice President, Finance and Accounting
(610) 487-0907

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2024 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.